Watch CBIH. Know when insiders buy.
One email the day a filing lands. Free.
CBIH
Cannabis Bioscience International Holdings, Inc.
0.00
+0.00 +33.33%
USD · close Sep 8
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
2
FLAG · shorts 2
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.3MP/E —DIV YIELD —FCF YIELD —REV TTM $124K −64.1%NET INCOME −$515KNET DEBT $217K52W 0.00 – 0.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 · Feb 28 | $11K | −25.0% | 72.8% | −$93K | −$104K | — | 0.00 | −$15K | — | — | Apr 16 |
| Q2 2026 · Nov 30 | $53K | −28.3% | 80.3% | −$96K | −$117K | — | 0.00 | −$5K | — | — | Apr 16 |
| Q1 2026 · Aug 31 | $24K | −86.5% | 66.4% | −$75K | −$83K | — | 0.00 | −$104K | — | — | Apr 16 |
| Q4 2025 · May 31derived | $35K | −53.9% | 87.0% | −$135K | −$212K | — | 0.00 | −$144K | — | — | Sep 22 |
| Q3 2025 · Feb 28 | $15K | −59.0% | -29.9% | −$129K | −$181K | — | 0.00 | −$83K | — | — | Apr 16 |
| Q2 2025 · Nov 30 | $74K | +16.5% | 89.5% | −$60K | −$80K | — | 0.00 | −$72K | — | — | Apr 16 |
| Q1 2025 · Aug 31 | $179K | +145.7% | 95.3% | −$98K | −$76K | — | 0.00 | −$30K | — | — | Apr 16 |
| Q4 2024 · May 31derived | $76K | +63.5% | 87.0% | −$30K | −$136K | — | 0.00 | −$174K | — | — | Sep 22 |
| Q3 2024 · Feb 29 | $36K | — | 67.6% | −$160K | −$209K | — | 0.00 | −$9K | — | — | May 9 |
| Q2 2024 · Nov 30 | $64K | — | 76.3% | −$95K | −$124K | — | 0.00 | −$221K | — | — | May 9 |
| Q1 2024 · Aug 31 | $73K | — | 87.9% | −$177K | −$182K | — | 0.00 | −$75K | — | — | May 9 |
| Q4 2023 · May 31derived | $46K | — | 65.5% | −$275K | −$276K | — | 0.00 | −$188K | — | — | Sep 16 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to May 31 | $303K | 86.8% | −$421K | −$549K | -181.1% | -0.00 | −$330K | — | — | — | — |
| FY2024 · to May 31 | $249K | 81.7% | −$486K | −$651K | -261.8% | -0.00 | −$479K | — | — | — | — |
| FY2023 · to May 31 | $317K | 70.5% | −$983K | −$1M | -325.9% | -0.00 | −$898K | — | — | — | — |
Every number comes from Cannabis Bioscience International Holdings, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.